CVRx Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 71
Employees
  • Latest Deal Type
  • Series G
  • Latest Deal Amount
  • $50M
Latest Deal Amount
  • Investors
  • 21

CVRx General Information

Description

Developer of implantable technology designed to provide treatment of high blood pressure. The company's technology is designed to trigger the body's own natural blood flow regulation system to treat high blood pressure and heart failure, enabling patients to begin treatment more quickly and result in a higher likelihood of successful treatment.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 9201 West Broadway Avenue
  • Suite 650
  • Minneapolis, MN 55445
  • United States
+1 (763) 000-0000

CVRx Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CVRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series G) 07-Jul-2020 $50M 00000 00000 Completed Generating Revenue
9. Debt - General 30-Sep-2019 000.00 00000 Completed Generating Revenue
8. Later Stage VC (Series G) 05-Aug-2016 00000 00000 00000 Completed Generating Revenue
7. Debt - General 22-Sep-2014 00000 Completed Generating Revenue
6. Later Stage VC (Series F) 30-Oct-2013 0000 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series E) 30-Jul-2008 000.00 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 09-May-2007 0000 00000 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 11-May-2006 000.00 000.00 0000 Completed Startup
2. Early Stage VC (Series B) 21-May-2003 $22.3M $30.4M 000.00 Completed Startup
1. Early Stage VC (Series A) 27-Jun-2001 $8.02M $8.02M 0000 Completed Startup
To view CVRx’s complete valuation and funding history, request access »

CVRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series G 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series F2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series E2 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series D2 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B2 2,963,069 $0.010000 8% $2.54 $2.54 1x $2.54 1.07%
Series A2 2,454,686 $0.010000 8% $2 $2 1x $2 0.89%
To view CVRx’s complete cap table history, request access »

CVRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of implantable technology designed to provide treatment of high blood pressure. The company's technology is de
Therapeutic Devices
Minneapolis, MN
71 As of 2016
00000
0000 0000-00-00
00000000000 00000

00000000

ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
00000000000 0000000
Berlin, Germany

00000000

prehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
00000000 0000000
Irvine, CA
000 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CVRx Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biotronik Corporation Berlin, Germany
000000000 00000000 Private Equity-Backed Irvine, CA 000 00000 0000000 0000 00000
000 0000000 Corporate Backed or Acquired Maple Grove, MN 00 000000&0
To view CVRx’s complete competitors history, request access »

CVRx Executive Team (8)

Name Title Board Seat Contact Info
Nadim Yared Chief Executive Officer, President & Board Member
John Brintnall Chief Financial Officer
Jared Oasheim Controller
Joseph DuPay Senior Vice President, Development & Operations
Julia Stubben Vice President, European Sales & Marketing
You’re viewing 5 of 8 executive team members. Get the full list »

CVRx Board Members (20)

Name Representing Role Since
Ali Behbahani MD New Enterprise Associates Board Member 000 0000
Claudia D'Augusta Ph.D Ysios Capital Board Observer 000 0000
Geoff Pardo Gilde Healthcare Partners Board Member 000 0000
John Nehra New Enterprise Associates Board Member 000 0000
Joseph Slattery Self Board Member 000 0000
You’re viewing 5 of 20 board members. Get the full list »

CVRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CVRx Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hatteras Venture Partners Venture Capital Minority 000 0000 000000 0
Treo Ventures Venture Capital Minority 000 0000 000000 0
Venrock Venture Capital Minority 000 0000 000000 0
Vensana Capital Venture Capital Minority 000 0000 000000 0
Horizon Technology Finance Lender/Debt Provider Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »